Skip to content

Dr. Bryan Deneuville

Active
Private limited companyfounded 2025active for 1 yearRue Saint-Jean 19B, 1435 Mont-Saint-Guibert, BelgiumKBO/BCE: BE 1022.746.323
Summary

Dr. Bryan Deneuville has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €11,172 and a net result of €8,172. The computed 12-month bankruptcy probability is 1.5% (low).

Overview

Official details

Source: KBO
Status
Active since 25-04-2025 Normal situation
Registered office
13 active companies are registered at this address 2 started in the 12 months before. Source: KBO register, as of 3 November 2026.
Activity
“La société peut également accomplir toute opération civile,mobilière ou immobilière en respectant le caractère…” (deed in French)From the articles, 15 activitiesNo NACE code in the KBO yet
Establishment unit
2.373.341.065 1435 Mont-Saint-Guibert, since 25-04-2025
Financial year end
30 September
Peppol
Reachable since 06-02-2026

Board and ownership

Board

Financial position

63 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
1.5%
Annual accounts to 30-09-2025
Gross margin
€14,403
Turnover
≈ €110,000
estimated
Profit
€8,172
Equity
€11,172
Total assets
€43,534
Score breakdownraises riskFounded in 2025No main activity registeredlowers riskLiquidity: current ratio 0.53, cash €11,896Size: total assets €43,534Show the evidence

Checked score

Score 2025
63 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially stronger than 45% of micro companies without a NACE code
Financial strength
Strong
Solvency 51
equity 25.7% of total assets
Liquidity 47
short-term debt 69.8% · cash 27.3%
Profitability 92
return on assets 18.8%
Bankruptcy probability within 12 months
1.5% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 05-2026: 2.4% 06-2026: 2.4%● unchanged vs 05-2026 07-2026: 2.5%▲ +0.1 percentage points vs 06-2026 08-2026: 2.9%▲ +0.4 percentage points vs 07-2026 09-2026: 3.0%▲ +0.1 percentage points vs 08-2026highest value 10-2026: 1.5%▼ -1.5 percentage points vs 09-2026lowest value 11-2026: 1.5%● unchanged vs 10-2026lowest value
Credit of up to €500 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.53, below 1. Short-term debt is 69.8% and cash 27.3% of total assets. 74.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 31% of them on solvency, 29% on liquidity and 74% on profitability.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Founded in 2025
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Liquidity: current ratio 0.53, cash €11,896
NBB · annual accounts
raises risk · No main activity registered
KBO
lowers risk · Size: total assets €43,534
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 24-03-2026, 37 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
37 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2025.
KBO publications

Recent changes

  1. · Gazette deed IncorporationStarting capital €3,000 · Appointment: DENEUVILLE Bryan Alain Albert Elvis (director)
All 2 events

Key facts about Dr. Bryan Deneuville

What is the company number of Dr. Bryan Deneuville?
The company number of Dr. Bryan Deneuville is 1022.746.323. The VAT number is the same number with BE in front: BE 1022.746.323.
Where is Dr. Bryan Deneuville based?
The registered office is at Rue Saint-Jean 19B, 1435 Mont-Saint-Guibert.Company details
What is the legal form of Dr. Bryan Deneuville?
The legal form of Dr. Bryan Deneuville is Private limited company (BV).
When was Dr. Bryan Deneuville founded?
Dr. Bryan Deneuville was founded on 25-04-2025.
Is Dr. Bryan Deneuville still active?
Yes, Dr. Bryan Deneuville is an active enterprise in the KBO register.
What is the turnover of Dr. Bryan Deneuville?
The turnover in financial year 2025 is ≈ €110,000. This figure is estimated from the gross margin of €14,403 and 6,321 comparable companies of the same size. It probably lies between €50,000 and €260,000. It is a rough estimate.Financials
Is Dr. Bryan Deneuville profitable?
In financial year 2025, Dr. Bryan Deneuville made a profit of €8,172.
Where can I find the annual accounts of Dr. Bryan Deneuville?
Dr. Bryan Deneuville filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.